KMB | ||
---|---|---|
OUTLOOK RATING 1..100 | 52 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 30 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 11 | |
PRICE GROWTH RATING 1..100 | 62 | |
P/E GROWTH RATING 1..100 | 73 | |
SEASONALITY SCORE 1..100 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
GINX | KMB | |
---|---|---|
RSI ODDS (%) | 2 days ago40% | 2 days ago42% |
Stochastic ODDS (%) | 2 days ago90% | 2 days ago47% |
Momentum ODDS (%) | 2 days ago56% | 2 days ago43% |
MACD ODDS (%) | 2 days ago63% | 2 days ago35% |
TrendWeek ODDS (%) | 2 days ago66% | 2 days ago46% |
TrendMonth ODDS (%) | 2 days ago54% | 2 days ago39% |
Advances ODDS (%) | 10 days ago88% | 22 days ago43% |
Declines ODDS (%) | 2 days ago59% | 4 days ago46% |
BollingerBands ODDS (%) | 2 days ago90% | 2 days ago51% |
Aroon ODDS (%) | 2 days ago90% | 2 days ago37% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
QBER | 24.71 | 0.01 | +0.05% |
TrueShares Quarterly Bear Hedge ETF | |||
NBCE | 32.68 | N/A | N/A |
Neuberger Berman China Equity ETF | |||
IBDS | 24.30 | -0.02 | -0.08% |
iShares iBonds Dec 2027 Term Corp ETF | |||
ARB | 28.95 | -0.06 | -0.20% |
AltShares Merger Arbitrage ETF | |||
PFUT | 25.61 | -0.22 | -0.85% |
Putnam Sustainable Future ETF |
A.I.dvisor tells us that GINX and GSK have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GINX and GSK's prices will move in lockstep.
Ticker / NAME | Correlation To GINX | 1D Price Change % | ||
---|---|---|---|---|
GINX | 100% | -0.86% | ||
GSK - GINX | 23% Poorly correlated | -1.64% | ||
KMB - GINX | 22% Poorly correlated | -1.78% | ||
FMS - GINX | 22% Poorly correlated | -2.44% | ||
RELX - GINX | 21% Poorly correlated | -0.19% | ||
SONY - GINX | 20% Poorly correlated | +1.67% | ||
More |